Overview

Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this survey is to prospectively investigate safety and efficacy in patients with hypertension treated with telmisartan in proper use in medical practice over a long period
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Telmisartan